Open Access
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study
Bruce Rashbaum
1
,
CD Spinner
2
,
Cheryl McDonald
3
,
Cristina Mussini
4
,
John Jezorwski
5
,
Donghan Luo
6
,
Erika Van Landuyt
7
,
Kimberley Brown
6
,
Eric Y Wong
8
1
Capital Medical Associates, Washington, DC, USA;
|
2
3
Tarrant County Infectious Disease Associates, Fort Worth, TX, USA;
|
5
Janssen Research & Development, LLC, Pennington, NJ, USA;
|
6
Janssen Research & Development, LLC, Titusville, NJ, USA;
|
7
Janssen Research & Development, Beerse, Belgium;
|
8
Janssen Scientific Affairs, LLC, Titusville, NJ, USA
|
Publication type: Journal Article
Publication date: 2019-01-02
scimago Q2
wos Q3
SJR: 0.693
CiteScore: 2.6
Impact factor: 1.8
ISSN: 25787489, 25787470
PubMed ID:
31303147
Infectious Diseases
Pharmacology (medical)
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
HIV Research and Clinical Practice
1 publication, 20%
|
|
|
Future Virology
1 publication, 20%
|
|
|
Frontiers in Pharmacology
1 publication, 20%
|
|
|
Frontiers in Medicine
1 publication, 20%
|
|
|
BMJ Open
1 publication, 20%
|
|
|
1
|
Publishers
|
1
2
|
|
|
Frontiers Media S.A.
2 publications, 40%
|
|
|
Taylor & Francis
1 publication, 20%
|
|
|
1 publication, 20%
|
|
|
BMJ
1 publication, 20%
|
|
|
1
2
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Total citations:
5
Citations from 2024:
2
(40%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Rashbaum B. et al. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study // HIV Research and Clinical Practice. 2019. Vol. 20. No. 1. pp. 24-33.
GOST all authors (up to 50)
Copy
Rashbaum B., Spinner C., McDonald C., Mussini C., Jezorwski J., Luo D., Van Landuyt E., Brown K., Wong E. Y. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study // HIV Research and Clinical Practice. 2019. Vol. 20. No. 1. pp. 24-33.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/15284336.2019.1608714
UR - https://doi.org/10.1080/15284336.2019.1608714
TI - Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study
T2 - HIV Research and Clinical Practice
AU - Rashbaum, Bruce
AU - Spinner, CD
AU - McDonald, Cheryl
AU - Mussini, Cristina
AU - Jezorwski, John
AU - Luo, Donghan
AU - Van Landuyt, Erika
AU - Brown, Kimberley
AU - Wong, Eric Y
PY - 2019
DA - 2019/01/02
PB - Taylor & Francis
SP - 24-33
IS - 1
VL - 20
PMID - 31303147
SN - 2578-7489
SN - 2578-7470
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_Rashbaum,
author = {Bruce Rashbaum and CD Spinner and Cheryl McDonald and Cristina Mussini and John Jezorwski and Donghan Luo and Erika Van Landuyt and Kimberley Brown and Eric Y Wong},
title = {Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study},
journal = {HIV Research and Clinical Practice},
year = {2019},
volume = {20},
publisher = {Taylor & Francis},
month = {jan},
url = {https://doi.org/10.1080/15284336.2019.1608714},
number = {1},
pages = {24--33},
doi = {10.1080/15284336.2019.1608714}
}
Cite this
MLA
Copy
Rashbaum, Bruce, et al. “Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study.” HIV Research and Clinical Practice, vol. 20, no. 1, Jan. 2019, pp. 24-33. https://doi.org/10.1080/15284336.2019.1608714.